EVALUATION OF NOVEL FORMULATION CONTAINING MOMORDICA DIOICA EXTRACT AGAINST EXPERIMENTALLY INDUCED CARDIAC FIBROSIS IN RATS Authors: Patel SK , CHAUDHARY HR AND GANDHI TR
ABSTRACT
In this investigation, the effectiveness of cubosomes filled with fruit extract from Momordica dioica
against experimentally induced cardiac fibrosis in rats will be assessed. Male Sprague Dawley rats were
given twice-weekly doses of deoxycorticosterone acetate (DOCA), 1% NaCl in drinking water, and
uninephrectomy to promote cardiac fibrosis. The experimental rats were split into four groups of eight
each, with the groups named Sham Control, Surgical Control, Model Control, and Treatment Control
(Formulation dose: 104 mg/kg). After the treatment protocol was followed, anthropometric,
hemodynamic, biochemical, ex-vivo Langendorff investigation, and antioxidant parameters were
carried out. The histology of the heart stained with Masson's trichrome was also investigated.
Momordica dioica fruit extract-loaded cubosomes had cardio-preventive benefits by reducing
blood pressure, preserving normal ECG patterns, and improving left ventricular functions, as
demonstrated by a substantial reduction in LVEDP. The therapy groups have higher serum
creatinine levels and lower levels of urea and blood urea nitrogen. The activity of antioxidant
enzymes was also increased. Additionally, cardiac homogenate from animals that had been treated had less collagen I and III. By looking at the animal hearts that had been stained with Masson's,
this protective effect was further demonstrated.
Keywords: Momordica dioica, Novel Cubosomes formulation, cardiac fibrosis Publication date: 01/10/2024 https://ijbpas.com/pdf/2024/October/MS_IJBPAS_2024_8267.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2024/13.10.8267